radiopharmaceuticals

Pharma

Lantheus considers potential $7B Curium buyout proposal: report

The potential $7 billion buyout deal in the radiopharmaceutical space could be weeks away, Bloomberg reported, citing people familiar with the matter.

Zoey Becker May 26, 2026 10:38am

Niowave starts building $75M plant to boost radioisotope supply

May 26, 2026 8:35am

Novartis stands by $5B Pluvicto goal despite EU regulatory setback

Apr 28, 2026 10:10am

Fierce Biotech

Regeneron rides into radiopharma via $2.1B biobucks Telix pact

Apr 13, 2026 7:24am

Novartis pledges nearly $480M to bolster China production, R&D

Mar 23, 2026 10:35am

Gates-backed TerraPower sketches out $450M radioisotope facility

Mar 18, 2026 10:40am